Moving Toward “Green” Development and Promoting Integrated Growth: Series of Highlight Reports on the High-Quality Development Achievements of Shijiazhuang Sihua Pharmaceutical Group—Part 3
Category:
发布时间:2022-08-17
【概要描述】
Over the past few days, our reporter has been conducting interviews at Shijiazhuang No. 4 Pharmaceutical Group. Walking through each of the company’s production zones, one almost feels as though they are strolling through a garden. This “garden-style” corporate environment leaves a lasting first impression on every visitor.
Lush green grass stretches out, and winding paths lead to secluded beauty.
Over the past few days, our reporter has been conducting interviews at Shijiazhuang No. 4 Pharmaceutical Group. Walking through each of the company’s production areas, one almost feels as though they are strolling through a garden. This “garden-style” corporate environment leaves a lasting “first impression” on every visitor.
Shijiazhuang Fourth Pharmaceutical Co., Ltd. has actively responded to the calls of the national, provincial, and municipal governments by fully, accurately, and comprehensively implementing the new development philosophy. The company coordinates and promotes the integrated development of economic, social, and ecological benefits, taking the lead in the industry in advocating the concept of “green pharmaceutical manufacturing.” It emphasizes the organic integration of key development factors—such as production growth, environmental protection, and comprehensive resource utilization—and applies this approach across every specific stage, including production operations, project construction, and integrated land use, thereby forging a new path toward industrialization. At the same time, the company conscientiously fulfills its social responsibilities by promoting employment, stimulating local economic development, and achieving an organic unity of economic, social, and ecological benefits.
Green is the Foundation of Industrial Development
Low-carbon, Circular, Cost Reduction, and Efficiency Enhancement
“Green” has become the most vibrant hallmark of the new era.
Next to the R&D Center building of Shijiazhuang Sihua Pharmaceutical Group lies a thoughtfully designed little garden. A fountain that jets and dances, coupled with a tranquil pool of shimmering blue water, is a feast for the eyes; within the pool, colorful koi of various sizes swim joyfully back and forth; and along the garden’s grapevines, clusters of ripening grapes gleam with an alluring sheen... This scene is a vivid snapshot of Shijiazhuang Sihua’s commitment to “green pharmaceuticals.”
Making blue skies, white clouds, green mountains, and clear waters the norm requires the concerted efforts of every enterprise. At Shijiazhuang Sihua Pharmaceutical, this commitment is reflected in every detail of daily operations. “Shijiazhuang Sihua Pharmaceutical adheres to the principles of ‘green pharmaceutical manufacturing’ and innovative development, achieving a level of comprehensive energy utilization that is among the most advanced in China. In addition, we collect and treat process wastewater—such as rinse water from bottles and stoppers, as well as steam condensate—and reuse it for watering plants and trees, fish farming, fountain systems, showering, and replenishing circulating water, resulting in a water reuse rate of 90%,” said Liu Miao, Manager of the Equipment Department at Shijiazhuang Sihua Pharmaceutical Group.
The production process is equally “green” throughout. In particular, with the development of smart factories, Shijiazhuang Sihua Pharmaceutical has achieved more precise, efficient, and secure production process management, significantly boosting production efficiency, enhancing product quality, and reducing energy consumption and various costs.
In the past, the visual inspection station in the production workshop of Shijiazhuang Sihua Pharmaceutical was the position with the highest labor demand, as every single product had to be examined by the naked eye to determine whether it was good or defective. Today, manual inspection has been entirely replaced by automated visual inspection machines, boosting production-line capacity while significantly reducing the need for manpower. The reporter observed that, under the control of these automated systems, each bottle is automatically captured in 150 images, which are then analyzed by software to automatically identify defects and divert any flawed products onto designated sorting lanes. Sun Simeng, the team leader of the visual-inspection line on Production Line 35 in Workshop 103, shared her profound impression: “The automated visual-inspection machines can precisely reject substandard products, eliminating the risk of missed defects caused by human error, thereby improving product quality and substantially reducing our workload—plus, our eyes no longer get tired.”
Through energy conservation and emission reduction, technological upgrading, and the adoption of new materials, technologies, and processes, Shijiazhuang Sihua Pharmaceutical has achieved green and sustainable development and has been successfully recognized as one of the first batch of Green Factories by the Ministry of Industry and Information Technology.
“A ‘Smart’ Automated Warehouse”
A “Model” of Intensive Development
Protect land and conserve resources to benefit future generations.
One particularly noteworthy “highlight” of Shijiazhuang No. 4 Pharmaceutical’s green development is its strong emphasis on intensive land use. Through scientific planning and rational layout, the company maximizes the economic and social benefits derived from its limited land resources.
At the three-dimensional logistics center of Shijiazhuang Sihua Pharmaceutical in the High-tech Zone, reporters witnessed a remarkable scene: large robotic arms, operating at a rate of 15 cartons per minute, continuously scan barcodes to “grasp” boxed pharmaceuticals from the conveyor belt and place them onto storage pallets. Once stacking is complete, the pallets are automatically transferred to automated electric shuttles. These driverless shuttles then transport the medications to automated stacker cranes, which, following pre-determined routes based on the drugs’ production dates, precisely allocate the products to more than 40,000 storage locations. The entire automated racking system stands 24 meters high, 95 meters wide, and 150 meters long. Meanwhile, 18 continuously operating stacker cranes execute inbound and outbound operations with pinpoint accuracy and agility, all guided by instructions from the information terminal.
At the site of the Sihua New-Formulation and Biopharmaceutical Industrial Park project in the Shijiazhuang Economic and Technological Development Zone, our reporter observed a newly constructed, “massive” intelligent automated high-bay warehouse. This is Sihua Pharmaceutical’s eighth such high-bay facility—and currently its largest. Intense equipment installation is underway inside, with commissioning expected by the end of August. “Standing 32 meters tall and offering more than 61,000 storage locations, the key advantage of this intelligent high-bay warehouse is its highly efficient land use,” said Zhao Yongzheng, Executive President of Shijiazhuang Sihua Pharmaceutical Group. The footprint of this high-bay warehouse is only about one-seventh that of a conventional flat-floor warehouse of comparable size. Moreover, thanks to its high degree of automation, inbound and outbound throughput is exceptionally fast. The entire warehouse complex, including operations and management staff, requires no more than eight people—roughly one-thirtieth the workforce needed for a similarly sized conventional warehouse.
Zhao Yongzheng further explained that, in line with the principles of “quality first, innovation first, intelligent manufacturing first, and energy conservation first” in pharmaceutical production—and with the additional guideline that “all new projects must be designed to remain state-of-the-art for at least a decade, if not longer, on a global scale”—Shijiazhuang No. 4 Pharmaceutical has adopted a long-term perspective. While ensuring the regular and systematic advancement of project development, the company places quality enhancement at the core of its strategy and aims to compete in both the domestic mid-to-high-end market and the international arena as the ultimate objective of its projects. To this end, it proactively benchmarks itself against world-class pharmaceutical companies, striving to establish itself as the “reference standard” for Chinese pharmaceuticals and focusing on achieving innovation and breakthroughs in critical areas such as pharmaceutical quality risk management and energy conservation and environmental protection. For instance, the Shijiazhuang No. 4 Pharmaceutical New-Formulation and Biopharmaceutical Industrial Park project—a key provincial and municipal initiative currently under construction—adopts internationally advanced design concepts and is being meticulously developed into a high-standard, high-quality model project with a truly global outlook.
Boldly Shouldering Social Responsibility
True Achievement Through the Joint Pursuit of Righteousness and Benefit
The essence of business lies in responsibility.
Shijiazhuang No.4 Pharmaceutical Co., Ltd. upholds integrity as its core principle and is committed to providing high-quality pharmaceutical products to society and delivering premium healthcare services to the general public. To date, the company has had 26 drug varieties comprising a total of 35 dosage forms and specifications pass the National Evaluation of Quality and Therapeutic Equivalence for Generic Drugs, and 8 varieties encompassing 11 dosage forms and specifications have been selected in national centralized drug procurement. These achievements have helped enhance drug accessibility, reduce the medication burden on patients, and contribute to the building of a Healthy China.
In recent years, and particularly since last year, Shijiazhuang Sihua Pharmaceutical has not only achieved rapid growth but has also remained committed to giving back to society, donating materials and funds totaling more than RMB 20 million. Notably, during the COVID-19 pandemic response, the company’s employees rose to the challenge, demonstrated unwavering dedication, and worked tirelessly to ensure the uninterrupted supply of essential medicines to over 4,000 large and medium-sized hospitals nationwide, thereby fully exemplifying Shijiazhuang Sihua Pharmaceutical’s sense of social responsibility in the new era.
“Since this spacious, clean, multi-level parking garage was completed, we no longer have to park on the street, worry about a lack of spaces or vehicle scratches, or fret over rain or snow,” said Guo Yaling from the Legal Department of Shijiazhuang Sihua Pharmaceutical Group, as she expertly drove her car into a newly commissioned multi-level parking facility.
The reporter learned that Shijiazhuang Sihua Pharmaceutical has proactively assumed its social responsibility by investing RMB 38 million to construct a five-story, multi-level parking garage with 1,500 parking spaces at its facility in the Shijiazhuang Economic and Technological Development Zone. This project not only addresses the longstanding challenge of parking for employees but also enhances workplace safety and significantly improves the surrounding environment.
“As a socially responsible enterprise, Shijiazhuang Sihua Pharmaceutical is committed to pursuing innovative, green, and high-quality development while conscientiously fulfilling its social responsibilities and striving to balance ethical principles with commercial interests,” said Wu Hengyao, President of Shijiazhuang Sihua Pharmaceutical Group. In recent years, in addition to rigorously implementing its social responsibilities in areas such as green production, the company has also made genuine efforts and delivered concrete results in creating employment opportunities and addressing the urgent, difficult, and pressing concerns of its employees.
In the lobby on the first floor of the office building of Shijiazhuang Sihua Pharmaceutical, the reporter observed relevant officials conducting interviews with candidates for several positions. “By establishing, extending, supplementing, and strengthening industrial chains, we have reinforced the strategic layout for industrial development, creating more than 1,100 new jobs since last year,” said Zhang Sumei, Deputy General Manager of the Strategic Development and Human Resources Center at Shijiazhuang Sihua Pharmaceutical Group. She added that, while expanding employment opportunities, the company also sought to enhance employees’ sense of pride and accomplishment. To this end, in October 2021, with strong support from the municipal human resources and social security authorities, the company established the city’s first batch of high-skilled talent training bases, thereby creating favorable conditions for employees’ career development and job stability.
A strong sense of responsibility is the root of a tree and the source of water; steadfastly honoring commitments and fulfilling duties will invariably bear the fruit of success. Shijiazhuang No. 4 Pharmaceutical, with its unwavering commitment to accountability, has successively been awarded numerous honors, including the National May Day Labor Award, the National Model Enterprise for Honoring Contracts and Maintaining Credit, the Hebei Provincial Government Quality Award, the All-China Federation of Industry and Commerce’s “Advanced Private Enterprise in Fighting the COVID-19 Pandemic,” and the Chinese Red Cross Dedication Medal.
Consciously integrate into the development of the provincial capital
Harmonious Coexistence Charts the “Blueprint”
Green development and harmonious coexistence.
As a pillar enterprise in the city’s biopharmaceutical industry, Shijiazhuang Sihua Pharmaceutical is committed to growing and advancing in tandem with the city’s economic and social development. The company is striving to build itself into an internationally renowned enterprise with a globally recognized brand, consciously integrating into the broader drive to develop the capital into a modern, international, and beautiful metropolis. It continuously achieves new milestones in high-quality development and endeavors to contribute to the city’s goal of surpassing RMB 1 trillion in economic output.
Looking to the future, Wu Hengyao stated: “Going forward, Shijiazhuang Sihua Pharmaceutical will align its efforts with the city’s drive for competitive development of the biopharmaceutical industry, take proactive measures, strengthen its sense of responsibility, and adopt more pragmatic initiatives to solidify the foundation for high-quality, green development, thereby contributing Sihua’s share to achieving breakthroughs in our city’s biopharmaceutical sector ahead of others.”
Currently, the Municipal Party Committee and the Municipal Government are steadfastly implementing the new development philosophy in a comprehensive, accurate, and all-round manner. They are actively working to build a modern industrial system characterized by green, low-carbon, and circular development, with a particular focus on fostering more than five industrial clusters each exceeding RMB 100 billion in scale—among them biopharmaceuticals—and have formulated and introduced a series of policies and measures to support enterprises in continuously achieving new breakthroughs in green, low-carbon, and circular development. Shijiazhuang Sihua Pharmaceutical has, through concrete actions, blazed a new path for transformation and upgrading, conducting valuable exploration and practice in green and low-carbon development. This fully demonstrates the pharmaceutical company’s strong sense of social responsibility and commitment, establishing it as a benchmark within the industry.
“Green and low-carbon development is vital to the quality of the city’s high-quality economic growth, and it is an ongoing process—there is no ‘finished state,’ only a ‘work-in-progress.’ We must unswervingly implement the arrangements and deployments made by the Municipal Party Committee and the Municipal Government and accelerate the establishment of a modern industrial system characterized by green, low-carbon, and circular development.” Heads of relevant municipal departments and industrial parks alike stated that, moving forward, under the strong leadership of the Municipal Party Committee and the Municipal Government, they will further cultivate a “shop assistant” mindset in serving enterprise development and project construction; rigorously implement the city’s suite of policies and measures designed to benefit businesses; strengthen communication and coordination with enterprises; provide thorough policy interpretation and publicity to ensure that businesses fully reap the benefits of these policies; comprehensively enhance the efficiency of government services; proactively offer coordination and support; do everything possible to address enterprises’ challenges and alleviate their difficulties; and effectively enforce scientific, precise, and law-based pollution control, thereby achieving an organic integration of economic, social, and ecological benefits.
“As the saying goes, ‘Many hands make light work.’” Green and low-carbon development has become one of the “essential courses” for enterprises across our city, and it is their inescapable responsibility to put such principles into practice. Looking ahead, we hope that more local enterprises will draw on the experience of Shijiazhuang Sihua Pharmaceutical Co., Ltd., vigorously advance innovation-driven, green, and high-quality development, and make new contributions to our city’s high-quality development and to the early realization of the goal of surpassing RMB 1 trillion in economic output, thereby celebrating the successful convening of the 20th National Congress of the Communist Party of China with outstanding achievements.
Moving forward in pursuit of “green” will lead us far!
Reprinted from: Shijiazhuang Daily
Keywords:
Recommended News
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091